Status:
UNKNOWN
Triple Negative Breast Cancer: Study of Molecular and Genetic Factors
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Breast cancer triples negatives (TN; 15 % of the cases) are characterized by a high histoprognostic grade, a strong proliferation, a strong metastatic power, and a worse prognosis than the other forms...
Eligibility Criteria
Inclusion
- women \> 18
- non metastatic breast cancer
- triple negative
- 5 years follow-up
- signed informed consent
Exclusion
- other cancer (except in situ)
- metastases at diagnosis
- impossibility of follow-up
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01434420
Start Date
March 1 2011
End Date
March 1 2020
Last Update
December 31 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre jean Perrin
Clermont-Ferrand, France, 63011
2
Hopital La Timone
Marseille, France, 13005
3
Institut Paoli-Calmettes
Marseille, France, 13009
4
Centre Antoine Lacassagne
Nice, France, 06189